{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:11:05Z","timestamp":1786975865750,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd009880.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000}}],"reference-count":199,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009880.pub3","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:41:57Z","timestamp":1589481717000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A comparison of different antibiotic regimens for the treatment of infective endocarditis"],"prefix":"10.1002","volume":"2020","author":[{"given":"Arturo J","family":"Mart\u00ed-Carvajal","sequence":"additional","affiliation":[{"name":"Facultad de Ciencias de la Salud Eugenio Espejo; Universidad UTE (Cochrane Ecuador); Quito Ecuador"},{"name":"School of Medicine; Universidad Francisco de Vitoria (Cochrane Madrid); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Dayer","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Taunton and Somerset NHS Trust; Taunton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucieni O","family":"Conterno","sequence":"additional","affiliation":[{"name":"Medical School, Department of Internal Medicine, Infectious Diseases Division; State University of Campinas (UNICAMP); Campinas Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro G","family":"Gonzalez Garay","sequence":"additional","affiliation":[{"name":"Methodology Research Unit; Instituto Nacional de Pediatr\u00eda; Mexico City Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Elena","family":"Mart\u00ed-Amarista","sequence":"additional","affiliation":[{"name":"Department of Family Medicine; Northwell Health Southside Hospital; Bay Shore New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2005.01598.x","article-title":"Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients","volume":"259","author":"Ruotsalainen","year":"2006","journal-title":"Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/320869","article-title":"Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin","volume":"33","author":"Fort\u00fan","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD009880.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Boucher","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.eimc.2009.07.015","article-title":"Daptomycin compared to standard therapy for the treatment of native valve endocarditis","volume":"28","author":"Kanafani","year":"2010","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/jac\/dkn372","article-title":"Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates","volume":"62","author":"Rehm","year":"2008","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0007|cit7","doi-asserted-by":"crossref","unstructured":"Peric\u00e0s JM Moreno A Almela M Garc\u00eda de la M\u00e0ria C Marco F Mu\u00f1oz P FOSIMI Investigators Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial Clinical Microbiology and Infections 2018 24 6 673 6 29408610","DOI":"10.1016\/j.cmi.2018.01.010"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/cid\/ciu580","article-title":"Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial","volume":"59","author":"Rio","year":"2014","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2012.11.006","article-title":"Partial oral treatment of endocarditis","volume":"165","author":"Iversen","year":"2013","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0011|cit11","first-page":"23889","article-title":"Ceftriaxone once daily for four weeks vs. ceftriaxone plus gentamicin for two weeks for the treatment of penicillin susceptible Streptococcal endocarditis","volume":"4","author":"Sexton","year":"1996","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/515038","article-title":"Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group","volume":"27","author":"Sexton","year":"1998","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-90-5-789","article-title":"Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers","volume":"90","author":"Abrams","year":"1979","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.39.2.525","article-title":"Right-sided endocarditis caused by Staphylococcus aureus in drug abusers","volume":"39","author":"Fort\u00fan","year":"1995","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.35.1.79","article-title":"Failure of treatment with teicoplanin at 6 milligrams\/kilogram\/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon","volume":"35","author":"Gilbert","year":"1991","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/AAC.25.1.16","article-title":"Twice-daily intramuscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers","volume":"25","author":"Greenman","year":"1984","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-97-4-496","article-title":"Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study","volume":"97","author":"Korzeniowski","year":"1982","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-125-12-199612150-00005","article-title":"Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial","volume":"125","author":"Ribera","year":"1996","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD009880.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/clinids\/13.Supplement_2.S160","article-title":"Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci","volume":"13","author":"Stamboulian","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0023|cit23","unstructured":"A clinical trial to study the safety and efficacy of combination drug, vancomycin and ceftriaxone compared to vancomycin in mild to severe bacterial infections who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2008\/091\/000060"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0024|cit24","unstructured":"Study to assess the efficacy, safety and pharmacokinetics of CF-301 compared with placebo in addition to standard-of-care antibiotic therapy in blood infections caused by S. aureus, including heart valve infections who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2016-003059-31"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0025|cit25","unstructured":"A study to assess the efficacy and safety of ceftobiprole medocaril compared to daptomycin in the treatment of Staphylococcus aureus bacteremia, including infective endocarditis who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2017-001699-43"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0026|cit26","unstructured":"Evaluaci\u00f3n de la eficacia y la seguridad de la combinaci\u00f3n de fosfomicina (F) e imipenem (I) para el tratamiento de la endocarditis infecciosa (EI) sobre v\u00e1lvula nativa o prot\u00e9sica por S. Aureus resistente a meticilina (SARM) who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2008-008683-28"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0027|cit27","unstructured":"An open-label randomized controlled trial of ampicillin\/cloxacillin and ceftriaxone for empirical treatment of infective endocarditis who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000032006"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0028|cit28","unstructured":"Phase 4 Efficacy and safety study of cubicin\u00ae with and without combination therapy in S. aureus infective endocarditis (SAIE) clinicaltrials.gov\/ct2\/show\/NCT00638157"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0029|cit29","unstructured":"Phase 2 study of safety, efficacy, and pharmacokinetics of higher doses of daptomycin and vancomycin in MRSA bacteremia (HDSAB) clinicaltrials.gov\/ct2\/show\/NCT00695903"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0030|cit30","unstructured":"A phase 3 telavancin Staphylococcus aureus (S. aureus) bacteremia trial clinicaltrials.gov\/ct2\/show\/NCT02208063"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0031|cit31","unstructured":"Oral switch during treatment of left-sided endocarditis due to multi-susceptible streptococcus clinicaltrials.gov\/ct2\/show\/NCT02701595"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0032|cit32","unstructured":"Oral switch during treatment of left-sided endocarditis due to multi-susceptible staphylococcus clinicaltrials.gov\/ct2\/show\/NCT02701608"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0033|cit33","unstructured":"Ceftobiprole in the treatment of patients with Staphylococcus aureus bacteremia clinicaltrials.gov\/show\/nct03138733"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0034|cit34","unstructured":"Efficacy and safety of dalbavancin compared to standard of care antibiotic therapy for the completion of treatment of patients with complicated bacteremia or infective endocarditis clinicaltrials.gov\/show\/nct03148756"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0035|cit35","unstructured":"Short-course antibiotic treatment in gram-positive cocci infective endocarditis (SATIE) clinicaltrials.gov\/ct2\/show\/NCT04222257"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0036|cit36","unstructured":"Clinical trial of telavancin versus standard intravenous therapy in the treatment of subjects with Staphylococcus aureus bacteremia including infective endocarditis apps.who.int\/trialsearch\/Trial2.aspx?TrialID=RBR-3p8g7n"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jcin.2014.09.013","article-title":"Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review","volume":"8","author":"Amat-Santos","year":"2015","journal-title":"JACC. Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-017-0574-9","article-title":"The changing epidemiology of infective endocarditis in the Twenty-First Century","volume":"19","author":"Ambrosioni","year":"2017","journal-title":"Current Infectious Disease Reports"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003495-200868040-00011","article-title":"Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection","volume":"68","author":"Anderson","year":"2008","journal-title":"Drugs"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jiac.2019.05.014","article-title":"The SOFA score could predict the severity and prognosis of infective endocarditis","volume":"25","author":"Asai","year":"2019","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0041|cit41","first-page":"21","article-title":"Infective endocarditis in Argentina. Results of the EIRA 3 study","volume":"86","author":"Avelana","year":"2018","journal-title":"Revista Argentina de Cardiolog\u00eda"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.11604\/pamj.2017.26.40.10020","article-title":"Infective endocarditis in Principal Hospital of Dakar: a retrospective study of 42 cases over 10 years","volume":"26","author":"Ba","year":"2017","journal-title":"Pan African Medical Journal"},{"issue":"15","key":"10.1002\/14651858.CD009880.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.cmi.2017.04.025","article-title":"Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis","volume":"23","author":"Bai","year":"2017","journal-title":"Clinical Microbiology and Infection"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"15","key":"10.1002\/14651858.CD009880.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Basch","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(94)90144-9","article-title":"Evaluation of new clinical criteria for the diagnosis of infective endocarditis","volume":"96","author":"Bayer","year":"1994","journal-title":"American Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/cid\/ciy064","article-title":"A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis","volume":"67","author":"Beganovic","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0049|cit49","doi-asserted-by":"crossref","unstructured":"Beteille E Guarana M Nucci M Infective endocarditis in neutropenic patients with viridans streptococci bacteraemia Clinical Microbiology and Infection 2018 24 8 916 7 29559393","DOI":"10.1016\/j.cmi.2018.03.012"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0050|cit50","first-page":"257","article-title":"Infective endocarditis in Argentina: what have we learned in the last 25 years ?","volume":"79","author":"Burgos","year":"2019","journal-title":"Medicina"},{"issue":"10021","key":"10.1002\/14651858.CD009880.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(15)00067-7","article-title":"Infective endocarditis","volume":"387","author":"Cahill","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1097\/CCM.0000000000003796","article-title":"Neurologic complications of infective endocarditis: a joint model for a septic thromboembolism and inflammatory small vessel disease","volume":"47","author":"Cantier","year":"2019","journal-title":"Critical Care Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD009880.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000495149","article-title":"Stroke in patients with infective endocarditis: a 15-year single-center cohort study","volume":"80","author":"Cao","year":"2018","journal-title":"European Neurology"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijcard.2015.04.123","article-title":"Clinical epidemiology in Italian registry of infective endocarditis (RIEI): focus on age, intravascular devices and enterococci","volume":"190","author":"Cecchi","year":"2015","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0055|cit55","first-page":"1219","volume-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","author":"Chambers","year":"2001"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0056|cit56","first-page":"1239","volume-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","author":"Chambers","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10096-015-2523-6","article-title":"Value of brain MRI in infective endocarditis: a narrative literature review","volume":"35","author":"Champey","year":"2016","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"e7586","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.idc.2009.06.004","article-title":"Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides","volume":"23","author":"Chen","year":"2009","journal-title":"Infectious Disease Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0060|cit60","first-page":"685","article-title":"Pathology and pathogenesis of rheumatic heart disease","volume":"50","author":"Chopra","year":"2007","journal-title":"Indian Journal of Pathology & Microbiology"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1099\/mic.0.000703","article-title":"Basal levels of (p)ppGpp differentially affect the pathogenesis of infective endocarditis in Enterococcus faecalis","volume":"164","author":"Colomer-Winter","year":"2018","journal-title":"Microbiology"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/597031","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.21037\/cdt.2016.08.09","article-title":"Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study","volume":"7","author":"Cresti","year":"2017","journal-title":"Cardiovascular Diagnosis and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.hrtlng.2015.04.006","article-title":"Haemophilus parainfluenzae aortic prosthetic valve endocarditis (PVE) successfully treated with oral levofloxacin","volume":"44","author":"Cunha","year":"2015","journal-title":"Heart and Lung"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.micinf.2010.10.016","article-title":"Platelet receptor polymorphisms do not influence Staphylococcus aureus-platelet interactions or infective endocarditis","volume":"13","author":"Daga","year":"2011","journal-title":"Microbes and Infection"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"e2018375","DOI":"10.1590\/0037-8682-0375-2018","article-title":"Epidemiological and clinical profile of infective endocarditis at a Brazilian tertiary care center: an eight-year prospective study","volume":"52","author":"Damasco","year":"2019","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0067|cit67","first-page":"GPP3","article-title":"Immune evasion by Staphylococcus aureus","volume":"7","author":"Jong","year":"2019","journal-title":"Microbiology Spectrum"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lpm.2019.04.006","article-title":"Infective endocarditis and specific situations: right heart, valve prosthesis, cardiac implantable electronic device","volume":"48","author":"Delahaye","year":"2019","journal-title":"Presse Medicale"},{"issue":"16","key":"10.1002\/14651858.CD009880.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/sim.6909","article-title":"Type-II generalized family-wise error rate formulas with application to sample size determination","volume":"35","author":"Delorme","year":"2016","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ihj.2017.06.019","article-title":"Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis","volume":"70","author":"Dhotre","year":"2018","journal-title":"Indian Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QCO.0b013e328010683e","article-title":"New agents for Staphylococcus aureus endocarditis","volume":"19","author":"Drees","year":"2006","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009880.pub3-BIB0072|cit72","first-page":"iv7","article-title":"Linezolid pharmacokinetics and pharmacodynamics in clinical treatment","volume":"66","author":"Dryden","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service","volume":"96","author":"Durack","year":"1994","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cjca.2019.02.006","article-title":"Trends and outcomes of infective endocarditis in adults with tetralogy of Fallot: a review of the national inpatient sample database","volume":"35","author":"Egbe","year":"2019","journal-title":"Canadian Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/23744235.2015.1129672","article-title":"Beta-haemolytic streptococcal endocarditis: clinical presentation, management and outcomes","volume":"48","author":"El Rafei","year":"2016","journal-title":"Infectious Diseases (London, England)"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.genhosppsych.2019.01.008","article-title":"Management of endocarditis among persons who inject drugs: a narrative review of surgical and psychiatric approaches and controversies","volume":"57","author":"Elbatarny","year":"2019","journal-title":"General Hospital Psychiatry"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-319-27784-4_8","volume-title":"Endocarditis: Diagnosis and Management","author":"Elmistekawy","year":"2016"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0078|cit78","doi-asserted-by":"crossref","unstructured":"Erdem H Puca E Ruch Y Santos L Ghanem-Zoubi N Argemi X Portraying infective endocarditis: results of multinational ID-IRI study European Journal of Clinical Microbiology and Infectious Diseases 2019 38 9 1753 63 31187307","DOI":"10.1007\/s10096-019-03607-x"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/dkl044","article-title":"The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials","volume":"57","author":"Falagas","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/dkm137","article-title":"Daptomycin for endocarditis and\/or bacteraemia: a systematic review of the experimental and clinical evidence","volume":"60","author":"Falagas","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nature Reviews. Microbiology"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nature Reviews. Microbiology"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-540-48348-9_11","volume-title":"The Daschner Guide to In-Hospital Antibiotic Therapy","author":"Frank","year":"2009"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMp1207437","article-title":"Getting the methods right - the Foundation of Patient-Centered Outcomes Research","volume":"367","author":"Gabriel","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/14656566.2019.1574753","article-title":"Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery","volume":"20","author":"Giacobbe","year":"2019","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD009880.pub3-BIB0086|cit86","first-page":"iv3","article-title":"Linezolid: safety and efficacy in special populations","volume":"66","author":"Gould","year":"2011","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0087|cit87","unstructured":"The GRADE Working Group GRADEpro Brozek J Oxman A Sch\u00fcnemann H 2008"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccc.2007.12.011","article-title":"Antibiotic adverse reactions and drug interactions","volume":"24","author":"Granowitz","year":"2008","journal-title":"Critical Care Clinics"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0089|cit89","first-page":"735","article-title":"Latent Q fever endocarditis in patients undergoing routine valve surgery","volume":"23","author":"Grisoli","year":"2014","journal-title":"Journal of Heart Valve Disease"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fcimb.2017.00286","article-title":"Epic immune battles of history: neutrophils vs. Staphylococcus aureus","volume":"7","author":"Guerra","year":"2017","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0091|cit91","first-page":"379","article-title":"Vancomycin nephrotoxicity: myths and facts","volume":"69","author":"Gupta","year":"2011","journal-title":"Netherlands Journal of Medicine"},{"issue":"7651","key":"10.1002\/14651858.CD009880.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence - imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence - publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence - indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"44","key":"10.1002\/14651858.CD009880.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)","volume":"36","author":"Habib","year":"2015","journal-title":"European Heart Journal"},{"issue":"39","key":"10.1002\/14651858.CD009880.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1093\/eurheartj\/ehz620","article-title":"Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study","volume":"40","author":"Habib","year":"2019","journal-title":"European Heart Journal"},{"issue":"7414","key":"10.1002\/14651858.CD009880.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0104|cit104","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00108-019-00664-4","article-title":"Current treatment of endocarditis: innovations and controversies","volume":"60","author":"Hitzenbichler","year":"2019","journal-title":"Der Internist"},{"issue":"11","key":"10.1002\/14651858.CD009880.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/hrt.2005.072595","article-title":"Epidemiology and antibiotic treatment of infective endocarditis: an update","volume":"92","author":"Hoen","year":"2006","journal-title":"Heart"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"16059","DOI":"10.1038\/nrdp.2016.59","article-title":"Infective endocarditis","volume":"2","author":"Holland","year":"2016","journal-title":"Nature Reviews. Disease Primers"},{"issue":"7211","key":"10.1002\/14651858.CD009880.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/CMR.00030-13","article-title":"A current perspective on daptomycin for the clinical microbiologist","volume":"26","author":"Humphries","year":"2013","journal-title":"Clinical Microbiology Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"3-4","key":"10.1002\/14651858.CD009880.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"10","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41569-019-0215-0","article-title":"Infective endocarditis: innovations in the management of an old disease","volume":"16","author":"Iung","year":"2019","journal-title":"Nature Reviews. Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.lpm.2019.04.009","article-title":"Infective endocarditis. Epidemiology, pathophysiology and histopathology","volume":"48","author":"Iung","year":"2019","journal-title":"Presse Medicale"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Jakuska P Ereminiene E Muliuolyte E Kosys V Pavlavicius L Zukovas G Predictors of early mortality after surgical treatment of infective endocarditis: a single-center experience Perfusion 2019 Sep 4 10.1177\/0267659119872345 31480970","DOI":"10.1177\/0267659119872345"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCULATIONAHA.114.011432","article-title":"Endocarditis pathogen promotes vegetation formation by inducing intravascular neutrophil extracellular traps through activated platelets","volume":"131","author":"Jung","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0116|cit116","first-page":"440","volume-title":"Harrison's Principles of Internal Medicine","author":"Karchmer","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11908-013-0346-0","article-title":"Pathophysiology of infective endocarditis","volume":"15","author":"Keynan","year":"2013","journal-title":"Current Infectious Disease Reports"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0118|cit118","first-page":"30","article-title":"Valvular heart disease in adults: infective endocarditis","volume":"457","author":"Khan","year":"2017","journal-title":"FP Essentials"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40119-019-00148-4","article-title":"Current evidence on oral antibiotics for infective endocarditis: a narrative review","volume":"8","author":"Kobayashi","year":"2019","journal-title":"Cardiology and Therapy"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0120|cit120","first-page":"544","article-title":"Etiology, risk factors and outcome of 1003 cases of infective endocarditis from a 33-year National Survey in the Slovak Republic: an increasing proportion of elderly patients","volume":"39","author":"Kr\u010dm\u00e9ry","year":"2019","journal-title":"Neuro Endocrinology Letters"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Kumar M Anstadt EJ Lopetegui Lia N Siddiqi MH Streptococcus viridans endocarditis affecting all four valves Cureus 2019 11 5 e4635 31312561","DOI":"10.7759\/cureus.4635"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14740338.2012.643866","article-title":"Adverse reactions to beta-lactam antimicrobials","volume":"11","author":"Lagace-Wiens","year":"2012","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1749-6632.2011.05962.x","article-title":"Linezolid, the first oxazolidinone antibacterial agent","volume":"1222","author":"Leach","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"ofz089","DOI":"10.1093\/ofid\/ofz089","article-title":"High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis","volume":"6","author":"Leahey","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4065\/mcp.2010.0639","article-title":"General principles of antimicrobial therapy","volume":"86","author":"Leekha","year":"2011","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0126|cit126","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0127|cit127","unstructured":"Leyva S Leyva E Fluoroquinolonas. Mecanismos de acci\u00f3n y resistencia, estructura, s\u00edntesis y reacciones fisicoqu\u00edmicas importantes para propiedades medicinales Bolet\u00edn de la Sociedad Qu\u00edmica de M\u00e9xico 2008 2 1 1 13"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.3390\/ijerph16122248","article-title":"Diabetes mellitus: an independent risk factor of in-hospital mortality in patients with infective endocarditis in a new era of clinical practice","volume":"16","author":"Lin","year":"2019","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/11536360-000000000-00000","article-title":"Safety profile of the fluoroquinolones: focus on levofloxacin","volume":"33","author":"Liu","year":"2010","journal-title":"Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ccd.27312","article-title":"Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement","volume":"91","author":"Lluri","year":"2018","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"9","key":"10.1002\/14651858.CD009880.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.ajem.2018.06.074","article-title":"Infectious endocarditis: an update for emergency clinicians","volume":"36","author":"Long","year":"2018","journal-title":"American Journal of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1213\/ANE.0000000000002741","article-title":"Significance, errors, power, and sample size: the blocking and tackling of statistics","volume":"126","author":"Mascha","year":"2018","journal-title":"Anesthesia and Analgesia"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0135|cit135","unstructured":"McKinney M 'Time is of the essence'. PCORI moves to implement comparative effectiveness research, funding Modern Healthcare 2012 42 5 12 3 22356074"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0136|cit136","first-page":"257","article-title":"Inflammasome activation can mediate tissue-specific pathogenesis or protection in Staphylococcus aureus infection","volume":"397","author":"Melehani","year":"2016","journal-title":"Current Topics in Microbiology and Immunology"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"e0201459","DOI":"10.1371\/journal.pone.0201459","article-title":"Aspergillus endocarditis: diagnostic criteria and predictors of outcome, a retrospective cohort study","volume":"13","author":"Meshaal","year":"2018","journal-title":"PLOS ONE"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3949\/ccjm.86a.18120","article-title":"Infective endocarditis: beyond the usual tests","volume":"86","author":"Mgbojikwe","year":"2019","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.4244\/EIJ-D-19-00247","article-title":"Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve Registry","volume":"15","author":"Moriyama","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0141|cit141","unstructured":"Moser C Elming H Helweg-Larsen J Christensen JJ Jensen KT Smerup MH Infectious endocarditis. Danish guidelines www.nbv.cardio.dk\/endocarditis"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12350-018-1333-5","article-title":"Guidelines in review: Comparison of ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults","volume":"26","author":"Murphy","year":"2019","journal-title":"Journal of Nuclear Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-0691.2006.01585.x","article-title":"Linezolid therapy for infective endocarditis","volume":"13","author":"Mu\u00f1oz","year":"2007","journal-title":"Clinical Microbiology and Infection"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"E1167","DOI":"10.3390\/jcm8081167","article-title":"National temporal trend analysis of infective endocarditis among patients infected with HIV in Spain (1997-2014): a retrospective study","volume":"8","author":"Mu\u00f1oz-Moreno","year":"2019","journal-title":"Journal of Clinical Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/PL00002042","article-title":"Diagnosis of endocarditis today: Duke criteria or clinical judgment?","volume":"26","author":"Naber","year":"2001","journal-title":"Herz"},{"issue":"7","key":"10.1002\/14651858.CD009880.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/0218492318798258","article-title":"Predictors of surgical outcome in isolated prosthetic mitral valve endocarditis","volume":"26","author":"Nagy","year":"2018","journal-title":"Asian Cardiovascular and Thoracic Annals"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.idc.2009.06.010","article-title":"Antibiotics for Gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin\/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin","volume":"23","author":"Nailor","year":"2009","journal-title":"Infectious Diseases Clinics of North America"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0148|cit148","first-page":"251","article-title":"Embolic complications in infective endocarditis: how can we predict using a Risk Evaluator Score (SORTIE or ABCDE)","volume":"32","author":"Nascimento","year":"2019","journal-title":"ABC Imagem Cardiovascular"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.micpath.2019.04.026","article-title":"Staphylococcus aureus versus neutrophil: scrutiny of ancient combat","volume":"131","author":"Nasser","year":"2019","journal-title":"Microbial Pathogenesis"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12879-019-3736-6","article-title":"Group A streptococcus endocarditis in children: 2 cases and a review of the literature","volume":"19","author":"Ogura","year":"2019","journal-title":"BMC Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00365549609037927","article-title":"Comparison of the von Reyn and Duke criteria for the diagnosis of infective endocarditis: a critical analysis of 161 episodes","volume":"28","author":"Olaison","year":"1996","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"172","DOI":"10.14503\/THIJ-13-3961","article-title":"Prosthetic valve endocarditis with valvular obstruction after transcatheter aortic valve replacement","volume":"42","author":"Pabilona","year":"2015","journal-title":"Texas Heart Institute Journal"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5694\/mja12.11703","article-title":"Determining research priorities for clinician-initiated trials in infectious diseases","volume":"198","author":"Paterson","year":"2013","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0155|cit155","first-page":"1189","volume-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","year":"2001"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0156|cit156","first-page":"1273","volume-title":"Goodman & Gilman's. The Pharmacological Basis of Therapeutics","year":"2001"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0157|cit157","first-page":"60","article-title":"Profile of infective endocarditis: at a tertiary care referral centre","volume":"66","author":"R","year":"2018","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0158|cit158","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ccd.28474","article-title":"Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease","volume":"94","author":"Sadeghi","year":"2019","journal-title":"Catheterization and Cardiovascular Interventions"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14503\/THIJ-15-5359","article-title":"Clinical risk factors for infective endocarditis in Staphylococcus aureus bacteremia","volume":"44","author":"Salvador","year":"2017","journal-title":"Texas Heart Institute Journal"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0161|cit161","doi-asserted-by":"crossref","unstructured":"Saraste A Knuuti J Guidelines in review: Comparison of ESC and AHA guidance for the diagnosis and management of infective endocarditis in adults. Are the differences clinically relevant? The European perspective Journal of Nuclear Cardiology 2019 26 1 309 12 30132186","DOI":"10.1007\/s12350-018-1414-5"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.lpm.2019.04.002","article-title":"Complications and prognosis of infective endocarditis","volume":"48","author":"Selton-Suty","year":"2019","journal-title":"Presse Medicale"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/pst.301","article-title":"Power and sample size when multiple endpoints are considered","volume":"6","author":"Senn","year":"2007","journal-title":"Pharmaceutical Statistics"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/IAI.00469-10","article-title":"Platelet activation and biofilm formation by Aerococcus urinae, an endocarditis-causing pathogen","volume":"78","author":"Shannon","year":"2010","journal-title":"Infection and Immunity"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/STROKEAHA.118.023443","article-title":"Risk factors for stroke in patients with sepsis and bloodstream infections","volume":"50","author":"Shao","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/jac\/dkt512","article-title":"Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study","volume":"69","author":"Shrestha","year":"2014","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0037-1606386","article-title":"Predictors of surgical outcome in isolated tricuspid valve endocarditis: single center experience of 60 patients","volume":"65","author":"Singer","year":"2017","journal-title":"Thoracic and Cardiovascular Surgeon"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0168|cit168","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-319-27784-4_9","volume-title":"Endocarditis: Diagnosis and Management","author":"Skinner","year":"2016"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"e82665","DOI":"10.1371\/journal.pone.0082665","article-title":"Infective endocarditis epidemiology over five decades: a systematic review","volume":"8","author":"Slipczuk","year":"2013","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3904\/kjim.2015.30.4.434","article-title":"Infective endocarditis involving an apparently structurally normal valve: new epidemiological trend?","volume":"30","author":"Song","year":"2015","journal-title":"Korean Journal of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458517695471","article-title":"The most frequently asked question to a statistician: the sample size","volume":"23","author":"Sormani","year":"2017","journal-title":"Multiple Sclerosis"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11910-019-0935-x","article-title":"Neurological complications of infective endocarditis","volume":"19","author":"Sotero","year":"2019","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0174|cit174","doi-asserted-by":"crossref","unstructured":"Sun BJ Choi SW Park KH Jang JY Kim DH Song JM Infective endocarditis involving apparently structurally normal valves in patients without previously recognized predisposing heart disease Journal of the American College of Cardiology 2015 65 3 307 9 25614430","DOI":"10.1016\/j.jacc.2014.10.046"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0175|cit175","first-page":"190","article-title":"Antimicrobial susceptibility against penicillin, ampicillin and vancomycin of viridans group Streptococcus in oral microbiota of patients at risk of infective endocarditis","volume":"24","author":"S\u00fcz\u00fck","year":"2016","journal-title":"Le Infezioni in Medicina"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0176|cit176","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-3-319-27784-4","volume-title":"Endocarditis: Diagnosis and Management","author":"Tam","year":"2016"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"e0174519","DOI":"10.1371\/journal.pone.0174519","article-title":"The prognosis of infective endocarditis treated with biological valves versus mechanical valves: a meta-analysis","volume":"12","author":"Tao","year":"2017","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.carpath.2006.05.009","article-title":"Pathology and pathogenesis of infective endocarditis in native heart valves","volume":"15","author":"Thiene","year":"2006","journal-title":"Cardiovascular Pathology"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/jac\/dkv115","article-title":"Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis","volume":"70","author":"Thornhill","year":"2015","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"11","key":"10.1002\/14651858.CD009880.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"4936","DOI":"10.1128\/IAI.01118-09","article-title":"Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis","volume":"78","author":"Thurlow","year":"2010","journal-title":"Infection and Immunity"},{"issue":"10","key":"10.1002\/14651858.CD009880.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cmi.2017.03.007","article-title":"International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines","volume":"23","author":"Tissot-Dupont","year":"2017","journal-title":"Clinical Microbiology and Infection"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.mcna.2010.04.006","article-title":"The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams","volume":"94","author":"Torres","year":"2010","journal-title":"Medical Clinics of North America"},{"issue":"14","key":"10.1002\/14651858.CD009880.pub3-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"e00766","DOI":"10.1128\/JB.00766-18","article-title":"\u0278Sa3mw prophage as a molecular regulatory switch of Staphylococcus aureus beta-toxin production","volume":"201","author":"Tran","year":"2019","journal-title":"Journal of Bacteriology"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40266-018-0614-7","article-title":"Infective endocarditis in the elderly: diagnostic and treatment options","volume":"36","author":"Ursi","year":"2019","journal-title":"Drugs and Aging"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s15010-019-01338-x","article-title":"Prognostic factors of mortality after surgery in infective endocarditis: systematic review and meta-analysis","volume":"47","author":"Varela Barca","year":"2019","journal-title":"Infection"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/1389557511209030202","article-title":"Daptomycin: a review of properties, clinical use, drug delivery and resistance","volume":"12","author":"Vilhena","year":"2012","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0187|cit187","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-3-319-27784-4_9","volume-title":"Endocarditis: Diagnosis and Management","author":"Vinh","year":"2016"},{"issue":"8","key":"10.1002\/14651858.CD009880.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10096-016-2660-6","article-title":"The causative agents in infective endocarditis: a systematic review comprising 33,214 cases","volume":"35","author":"Vogkou","year":"2016","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"4 Part 1","key":"10.1002\/14651858.CD009880.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-94-4-505","article-title":"Infective endocarditis: an analysis based on strict case definitions","volume":"94","author":"Von Reyn","year":"1981","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD009880.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"e004744","DOI":"10.1136\/bmjopen-2013-004744","article-title":"The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials","volume":"4","author":"Wang","year":"2014","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD009880.pub3-BIB0191|cit191","first-page":"iii25","article-title":"Daptomycin in endocarditis and bacteraemia: a British perspective","volume":"62 Suppl 3","author":"Warren","year":"2008","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"12","key":"10.1002\/14651858.CD009880.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/qjmed\/hcz191","article-title":"Age, creatinine, and ejection fraction (ACEF) score: a simple risk-stratified method for infective endocarditis","volume":"112","author":"Wei","year":"2019","journal-title":"QJM: Monthly Journal of the Association of Physicians"},{"issue":"1","key":"10.1002\/14651858.CD009880.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrcardio.2013.174","article-title":"Mechanisms of infective endocarditis: pathogen-host interaction and risk states","volume":"11","author":"Werdan","year":"2014","journal-title":"Nature Reviews. Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11908-006-0071-z","article-title":"New concepts in the pathophysiology of infective endocarditis","volume":"8","author":"Widmer","year":"2006","journal-title":"Current Infectious Disease Reports"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","article-title":"Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy","volume":"37","author":"Wong-Beringer","year":"2011","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD009880.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jtcvs.2017.09.013","article-title":"Diabetes mellitus adversely affects mortality and recurrence after valve surgery for infective endocarditis","volume":"155","author":"Yoshioka","year":"2018","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"5","key":"10.1002\/14651858.CD009880.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jac\/dkm324","article-title":"Antimicrobials for right-sided endocarditis in intravenous drug users: a systematic review","volume":"60","author":"Yung","year":"2007","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD009880.pub3-BIB0198|cit198","first-page":"187","article-title":"Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019","volume":"48","author":"\u015eim\u015fek-Yavuz","year":"2020","journal-title":"Tu\u0308rk Kardiyoloji Derneg\u0306i ars\u0327ivi"},{"issue":"4","key":"10.1002\/14651858.CD009880.pub3-BIB0199|cit199","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009880.pub2","article-title":"A comparison of different antibiotic regimens for the treatment of infective endocarditis","author":"Marti-Carvajal","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T03:25:31Z","timestamp":1638415531000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009880.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":199,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009880.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]}}}